Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer. - Wikidata - awgldk - TriplyDB

Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.

Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.

http://www.wikidata.org/entity/Q39325995

about

The role of BST-2/Tetherin in host protection and disease manifestation Targeted therapy for HM1.24 (CD317) on multiple myeloma cells BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer.Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma A proteomic analysis of the endometrium in obese and overweight women with recurrent miscarriage: preliminary evidence for an endometrial defect.Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas.Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.Advances in the proteomic discovery of novel therapeutic targets in cancer.Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors Mass spectrometry-based membrane proteomics in cancer biomarker discovery.Coupling enrichment methods with proteomics for understanding and treating disease.Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis.Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis.Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.A proteomic approach for the identification of biomarkers in endometrial cancer uterine aspirate.Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.Surface functionalization dependent subcellular localization of Superparamagnetic nanoparticle in plasma membrane and endosome.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression Profiles

P2860

Q26752737-9F483B7E-6CCC-4124-BF5B-17B5D1EC85A2 Q27026161-A98A3175-44EB-4BFE-9A29-D071A9962CA2 Q33631179-C984CA56-AA24-468B-AFC2-FC119D39A6B7 Q33648638-4A2A2E43-6205-4923-BEFB-FDB32BD7985C Q34545119-6EB50CB4-BD66-4B81-A4AC-867C4CF65816 Q35911232-1A56B28D-A883-48F2-B743-0316A0B24057 Q36262941-F8E51BEB-013F-4AFC-9C01-97F9D7106EE7 Q36662048-CA22E5A1-45B7-4A55-B86A-4139DDE36BB0 Q37061381-5B619B12-48C9-4150-8AEF-DCFB9D4AF549 Q37260569-16CAA1A5-4486-4B19-9BA7-AE18F98E9151 Q37663907-61CFB251-DF5C-4843-98FC-A3D3CD7B7FC5 Q38211274-F7C4A58B-F0D1-457B-BE46-9268DB473368 Q38293824-AEB13363-7C97-44FE-B4EF-5AB1655E638C Q38825662-DFAB4893-7E9D-4CEB-8C39-A90FFD2FDD5E Q39146365-D5FABBC0-0858-4F99-A619-6B6B3236A1AE Q39479395-F56BD21C-4199-43B8-A838-C90AA4DB6D2F Q40979460-3FC2AA95-17F0-40EC-BCB8-9A0E4B92B651 Q47193665-7EC253F0-0D18-4A7F-B980-452237B45CE3 Q47750583-45E7BE93-36F6-4A1D-813A-0D32AA5C1AE4 Q50312620-227B170F-687F-486F-AD8D-58DDB0841C71 Q52363678-C3DC5666-6296-4B89-9A93-8E7E4BA02A5B Q57791776-EED69C2C-2CEE-43CF-AC62-EDAC7ABAC367

P2860

Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.

http://www.wikidata.org/entity/Q39325995

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Plasma membrane proteomics ide ...... target in endometrial cancer.

@en

Plasma membrane proteomics ide ...... target in endometrial cancer.

@nl

type

label

Plasma membrane proteomics ide ...... target in endometrial cancer.

@en

Plasma membrane proteomics ide ...... target in endometrial cancer.

@nl

prefLabel

Plasma membrane proteomics ide ...... target in endometrial cancer.

@en

Plasma membrane proteomics ide ...... target in endometrial cancer.

@nl

P1433

Q39325995-3DC96000-76EF-4087-911B-0CF63C043247

P1476

Q39325995-D6431421-DA8C-4ED0-94A8-CC03470CA514

P2093

Q39325995-095293CF-7303-4F4D-89D1-5BE44410DBFD

Q39325995-11C39F50-F84B-44C8-856A-E1267E5737FD

Q39325995-174F4C11-92F6-4399-9053-81A8D397E977

Q39325995-25338846-5E65-4693-996F-3C91C2EC0341

Q39325995-46D762AC-7FB2-4D4A-82F2-D4B247C1412C

Q39325995-A2BD3008-FF37-4F20-AF1C-6038DD853C62

Q39325995-DA107490-76BC-46AE-A08B-967C07EC7B66

Q39325995-F0A81A57-70A0-4FB6-A42E-D04EE11773F6

Q39325995-FF9A4CD3-7F39-49F9-A597-1311D65EA7DB

P2860

Q39325995-07209830-FAF1-484A-81C3-56DE45452091

Q39325995-0BD8D653-07D9-478C-A2EF-52EA26D2907B

Q39325995-0DFF1263-CF5C-4B50-A577-B1E486D49F63

Q39325995-11B75243-E6F3-4FA0-973A-1223E2EC39D9

Q39325995-194EE443-BA88-43EF-A7B4-74D0E17B5075

Q39325995-1CAE77D7-6695-4601-B354-AD297095CA75

Q39325995-237BF363-80EC-4B04-800B-D2521F32754E

Q39325995-266C72E3-4808-4CA9-A11D-6C04CDB95020

Q39325995-2C312EFF-76C3-45EA-9089-313A8336211E

Q39325995-2F2DB660-A302-4BC5-81F7-8D9CB92ED56B

P304

Q39325995-318A2460-8D38-4D7E-87D4-0D758D60ED2A

P31

Q39325995-10B0C09F-86EA-4D80-A5FB-D734434EC349

P356

Q39325995-BF31906B-2AF2-40F2-B126-6BE9EF115B62

P433

Q39325995-7F243CFE-CE2B-47F5-9AE8-289ABC7EA7F8

P478

Q39325995-3EC1607D-5CB1-4B3F-9012-1F02B58CBCE8

P50

Q39325995-7B4DE750-7FF8-484B-BCD4-38C75E92D0D0

Q39325995-AADD8790-0172-413F-AB8C-3963C29F847B

Q39325995-F5E720A8-BB4A-4466-AEC9-F24027F95989

Q39325995-FE61247A-BFEC-4942-9159-22F0006BA7D8

P577

Q39325995-E076D729-A683-4C10-9F53-946A243B15F4

P5875

Q39325995-C9CBE930-C0FE-40D3-AA90-D245D79B826D

P698

Q39325995-BE2FFA83-A00D-47FB-BF43-1F530D61CE99

P356

P1433

International Journal of Cancer

P1476

Plasma membrane proteomics ide ...... c target in endometrial cancer

@en

P2093

Akiko Morimoto

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Yoshino

http://www.w3.org/2001/XMLSchema#string

Kota Iwahori

http://www.w3.org/2001/XMLSchema#string

Masami Fujita

http://www.w3.org/2001/XMLSchema#string

Satoru Kyo

http://www.w3.org/2001/XMLSchema#string

Tadashi Kimura

http://www.w3.org/2001/XMLSchema#string

Takayuki Enomoto

http://www.w3.org/2001/XMLSchema#string

Takuhei Yokoyama

http://www.w3.org/2001/XMLSchema#string

Yutaka Ueda

http://www.w3.org/2001/XMLSchema#string

P2860

Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Cancer statistics, 2010

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping.

P304

472-484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.27679

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Shinya Matsuzaki

Minoru Fujimoto

P577

2012-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228063380

http://www.w3.org/2001/XMLSchema#string

P698

22729361

http://www.w3.org/2001/XMLSchema#string